Scholarlink

Purpose <p>To evaluate the incidence of new-onset Hypertensive Disorders of Pregnancy (HDP) in donor sperm IVF (DS-IVF) compared with partner sperm IVF (PS-IVF) pregnancies.</p> Methods <p>We retrospectively analyzed a total of 855 DS-IVF cycles and 4,816 PS-IVF cycles of pregnancies delivering after 20&#xa0;weeks’ gestation achieved live birth between January 2010 and December 2022. All patients underwent fresh embryo transfer after oocyte retrieval. The incidence of new-onset HDP was compared between the two groups.</p> Results <p>The overall incidence of new-onset HDP was 1.7%, with rates of 2.7% in DS-IVF group and 1.6% in PS-IVF group. Multivariate Analysis of risk factors in the entire cohort identified twin pregnancy (OR, 2.483: 95%CI: 1.649–3.739, <i>P</i> &lt; 0.001), elevated body mass index (BMI) (OR, 1.150: 95%CI: 1.095–1.209, <i>P</i> &lt; 0.001), and the use of donor sperm (OR, 2.063: 95%CI: 1.229–3.463, <i>P</i> = 0.006) as independent risk factors for new-onset HDP. In subgroup analyses of both DS-IVF and PS-IVF cohorts, twin pregnancy [DS-IVF: OR, 2.575: 95%CI: 1.085–6.115, <i>P</i> = 0.032; PS-IVF: OR, 2.454: 95%CI: 1.542–3.906, <i>p</i> &lt; 0.001] and elevated BMI&#xa0;[DS-IVF: OR, 1.152: 95%CI: 1.026–1.292, <i>P</i> = 0.016; PS-IVF: OR, 1.150: 95%CI: 1.089–1.215, <i>p</i> &lt; 0.001] were identified as independent risk factors for new-onset HDP.</p> Conclusion <p>The use of donor sperm is an independent risk factor for new-onset HDP in IVF-conceived pregnancies.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Donor sperm IVF pregnancies exhibit elevated risk of new-onset hypertensive disorders: a retrospective cohort study

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年2月24日

查看全文
  • Binbin Tu,
  • Mengjie Fan,
  • Ping Liu,
  • Rong Li,
  • Jie Qiao,
  • Rui Yang

摘要

Purpose

To evaluate the incidence of new-onset Hypertensive Disorders of Pregnancy (HDP) in donor sperm IVF (DS-IVF) compared with partner sperm IVF (PS-IVF) pregnancies.

Methods

We retrospectively analyzed a total of 855 DS-IVF cycles and 4,816 PS-IVF cycles of pregnancies delivering after 20 weeks’ gestation achieved live birth between January 2010 and December 2022. All patients underwent fresh embryo transfer after oocyte retrieval. The incidence of new-onset HDP was compared between the two groups.

Results

The overall incidence of new-onset HDP was 1.7%, with rates of 2.7% in DS-IVF group and 1.6% in PS-IVF group. Multivariate Analysis of risk factors in the entire cohort identified twin pregnancy (OR, 2.483: 95%CI: 1.649–3.739, P < 0.001), elevated body mass index (BMI) (OR, 1.150: 95%CI: 1.095–1.209, P < 0.001), and the use of donor sperm (OR, 2.063: 95%CI: 1.229–3.463, P = 0.006) as independent risk factors for new-onset HDP. In subgroup analyses of both DS-IVF and PS-IVF cohorts, twin pregnancy [DS-IVF: OR, 2.575: 95%CI: 1.085–6.115, P = 0.032; PS-IVF: OR, 2.454: 95%CI: 1.542–3.906, p < 0.001] and elevated BMI [DS-IVF: OR, 1.152: 95%CI: 1.026–1.292, P = 0.016; PS-IVF: OR, 1.150: 95%CI: 1.089–1.215, p < 0.001] were identified as independent risk factors for new-onset HDP.

Conclusion

The use of donor sperm is an independent risk factor for new-onset HDP in IVF-conceived pregnancies.